2026 Geromedicine Conference | Mr Wang Qingyun, Yong Loo Lin School of Medicine, NUS

Watch the oral poster presentation by Mr Wang Qingyun, PhD Student at the Yong Loo Lin School of Medicine, NUS, at the NUS Academy for Healthy Longevity’s 2026 Geromedicine Conference. This presentation explores research into the effects of Ozempic, an FDA-approved drug, on healthy longevity in Caenorhabditis elegans. Mr Wang discusses how the findings link the drug’s effects to neuronal inhibition of the mechanistic target of rapamycin (mTOR) pathway, offering insights into the biological mechanisms that may influence ageing and healthspan. The study contributes to ongoing research into drug repurposing and the development of evidence-based gerotherapeutics, while highlighting the importance of further investigation before translating findings from model organisms to human health. The 2026 Geromedicine Conference brings together researchers, clinicians, and industry experts advancing the science of ageing and exploring innovative approaches to extending healthspan. #Geromedicine #HealthyLongevity #PrecisionGeromedicine #AgeingResearch #Ozempic #Semaglutide #CElegans #mTOR #Gerotherapeutics #NUSMedicine